Peer-reviewed insights, clinical data, and mechanism-of-action breakdowns across our peptide and longevity research catalog.
A plain-English guide to purity %, HPLC, LC-MS, residual solvents, and what matters for lab documentation.
Shipping, storage temperatures, light exposure, reconstitution considerations, and general lab handling reminders.
FDA printable handout covering home/travel sharps disposal best practices to reduce needle-stick injuries.
Clinic-grade step-by-step subcutaneous injection technique and disposal guidance.
Primary-source list of prohibited substances/methods for tested athletes (includes peptide hormones/growth factors categories).
Extensively studied for tendon-to-bone healing, gut tissue repair, and accelerated wound recovery.
Research focuses on muscle repair, reduced inflammation, and improved flexibility through upregulation of cell-building proteins.
Studied for regulation of sleep-wake cycles, stress reduction, and normalization of disturbed circadian rhythms.
Research explores metabolic regulation, insulin sensitivity, exercise mimicry, and mitochondrial function in aging.
Studied for anxiolytic effects, cognitive enhancement, BDNF modulation, and immune system regulation without sedation.
Research centers on cellular aging reversal, sirtuin activation, mitochondrial function, and neuroprotection.
Extensively studied in CIRS/mold illness protocols, pulmonary hypertension, and neuroinflammatory conditions.
Phase 2 trials demonstrated up to 24% body weight reduction at 48 weeks. Studied for obesity, type 2 diabetes, and metabolic syndrome.
Phase 2 trials demonstrated up to 24% body weight reduction at 48 weeks. Higher dose vial reduces reconstitution frequency.
Combines four peptides studied for tissue repair, anti-inflammation, copper-mediated collagen synthesis, and antimicrobial activity.
FDA-approved analogue studied for weight management, cardiovascular risk reduction, hepatic steatosis improvement, and emerging neuroprotective effects.
Studied for melanocortin receptor-mediated effects on hypothalamic signaling cascades. FDA-approved analogue (Vyleesi) validated the MC4R mechanism.
Extensively studied for immune modulation, dendritic cell activation, T-cell differentiation, and restoring immune competence in immunocompromised models.
Research demonstrates telomerase activation in human somatic cells, with implications for cellular senescence reversal and age-related decline.
Studied for collagen synthesis upregulation, decorin and TIMP expression in dermal fibroblasts, wound healing acceleration, and skin remodeling.
Studied for selective GH release without affecting cortisol, prolactin, or ACTH. Favorable safety profile among GH secretagogues.
Combined GHRH + GHS pathway activation produces amplified pulsatile GH release and elevated IGF-1 compared to either peptide alone.
Studied for NF-kB pathway inhibition, inflammatory cytokine reduction, gut mucosal healing, and broad-spectrum antimicrobial activity.
Studied as a senolytic agent that selectively eliminates senescent cells while sparing healthy cells. Demonstrated restoration of fitness and organ function in aged models.
Combines BPC-157 angiogenesis and NO signaling with TB-500 cell migration and anti-fibrotic activity for complementary tissue repair mechanisms.
From exendin-4 to retatrutide — the complete history and future of GLP-1 receptor agonists in obesity, diabetes, cardiovascular, and neurological research.
An overview of the most promising peptide compounds in aging research — from NAD+ precursors and senolytics to telomerase activators and mitochondrial peptides.
How naturally occurring host defense peptides like LL-37, defensins, and magainin could address the growing crisis of antibiotic-resistant infections.
Breaking the injection barrier — how new delivery technologies are making peptide therapeutics accessible through oral pills, nasal sprays, and skin patches.
How peptides that modulate neurotrophic factors are being studied for cognitive enhancement, neuroprotection, and recovery from neurological injury.
How the first dual incretin agonist achieved unprecedented weight loss and glycemic outcomes in the SURMOUNT and SURPASS clinical programs.
A multimodal peptide preparation studied for stroke recovery, traumatic brain injury, and neurodegenerative disease with over 200 clinical studies.
Research on the synthetic alpha-MSH analogue affecting pigmentation, appetite, and sexual function through MC1R-MC5R activation.
Step-by-step protocol for reconstituting peptide powder with bacteriostatic water, including concentration calculations and storage.
Understanding chromatography reports --- peaks, purity ranges, retention times, and red flags in peptide COAs.
Exploring the peptide that disrupts the FOXO4-p53 interaction to selectively eliminate senescent cells in aging research.
The most selective ghrelin mimetic — promoting GH release without significant effects on cortisol, prolactin, or appetite.
Evidence-based storage protocols --- freezer vs refrigerator, light sensitivity, reconstituted vs lyophilized shelf life.
Head-to-head comparison --- NO pathway vs actin sequestration, gut vs musculoskeletal, combination protocols.
Which peptides dissolve in water, DMSO, or acetic acid --- and why solvent choice matters for experiments.
Biosynthesis pathways, bioavailability, Yoshino vs Trammell data, which crosses cell membranes.
A semi-synthetic polysaccharide studied for osteoarthritis, interstitial cystitis, and cartilage repair through multiple anti-inflammatory pathways.
HPLC purity vs net peptide content, TFA salt weight, batch variability, and what standards exist.
Receptor profiles, clinical trial weight loss data, side effects, mechanistic differences.
Research on the only human cathelicidin --- its role in innate immunity, wound healing, and potential applications in antibiotic-resistant infection research.
Tuftsin vs ACTH analogue, anxiolytic vs cognitive, GABAergic vs BDNF mechanisms.
How an octapeptide mimics botulinum toxin A mechanism to reduce SNARE complex formation and muscle contraction at the neuromuscular junction.
Collagen remodeling vs angiogenic repair, TIMPs/decorin vs NO/VEGF, topical vs systemic.
The neuropeptide that controls GnRH release and its emerging role in fertility research, metabolic regulation, and behavioral neuroscience.
The tetrapeptide Ala-Glu-Asp-Gly and its studied effects on pineal function, circadian rhythm normalization, and neuroendocrine aging.
How a modified fragment of human growth hormone (hGH 176-191) stimulates lipolysis without the growth-promoting effects of full GH.
mTORC1 vs mTORC2, downstream targets, autophagy regulation, rapamycin mechanism, MOTS-c AMPK activation.
How SIRT1-SIRT7 coordinate metabolic adaptation, DNA repair, and stress resistance via NAD+ cofactor.
A hexapeptide analogue of angiotensin IV with potency 10 million times greater than BDNF in promoting synaptic connectivity and cognitive function.
MC1R-MC5R --- pigmentation, appetite, sexual function, inflammation through one peptide signaling family.
Hypothalamic-pituitary GH axis and how CJC-1295, ipamorelin, GHRP-6 modulate pulsatile GH release.
How multiple research peptides converge on the NO-cGMP pathway --- endothelial function, cytoprotection, tissue repair.
